Advertisement
News
Subscribe to MDT Magazine News

Isis Pharmaceuticals to Present at The Wells Fargo 2010 Healthcare Conference

June 16, 2010 3:40 am | by Bio-Medicine.Org | Comments

CARLSBAD, Calif. , June 16 /- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the leader in antisense therapeutics, today announced that management will present a company overview at Wells Fargo's 2010 Healthcare Conference on Wednesday, June 23, 2010 at 2:00 p.m. ET at the InterContinental...

TOPICS:

HealthTronics says Cryocare CS system approved(17)

June 15, 2010 11:10 pm | by The Associated Press | Comments

Medical equipment maker HealthTronics Inc. said Tuesday that it received Food and Drug Administration clearance for the Cryocare CS system, which uses extreme cold to treat cancer of the kidneys and prostate.The Cryocare system includes ultrasound technology, insulated cryoprobes, and a...

Startup to Offer Patients a Genetic Profile of their Cancer

June 15, 2010 8:39 pm | by Massachusetts Institute of Technology | Comments

Foundation Medicine will provide a personalized picture of a patient's disease.

Advertisement

Plastic Antibodies Fight Toxins

June 15, 2010 8:39 pm | by Massachusetts Institute of Technology | Comments

Polymers that mimic the body's natural defenses could be a new class of inexpensive therapeutics.

Little is understood about alcohol's effect on fetal development, Georgetown researchers say

June 15, 2010 8:38 pm | by EurekAlert | Comments

(Georgetown University Medical Center) It's long been known that alcohol use in pregnancy can lead to children with mental retardation and birth defects, but researchers who study fetal alcohol syndrome have not made definitive progress on preventing the disorder, detecting it...

TOPICS:

Novel paclitaxel formulation encouraging for treating advanced lung cancer

June 15, 2010 3:38 pm | by EurekAlert | Comments

(International Association for the Study of Lung Cancer) The June edition of the Journal of Thoracic Oncology features a study aimed at determining the optimal dose of the chemotherapy drug nab-paclitaxel with carboplatin as a first-line therapy in patients with non-small cell lung...

TOPICS:

Inflammatory diseases: Scientists identify antiviral defense

June 15, 2010 12:38 pm | by EurekAlert | Comments

(University of Montreal) Canadian researchers have discovered a new way the body combats respiratory viral infections. In the prestigious journal PLoS Pathogens, scientists from the University of Montreal and the University of Montreal Hospital Research Center explain how the NOX2...

TOPICS:

Lung cancer research concludes that early diagnosis as key for improving survival

June 15, 2010 12:38 pm | by EurekAlert | Comments

(International Association for the Study of Lung Cancer) Research published in the June edition of the Journal of Thoracic Oncology sought to investigate the time trends of surgical outcomes of patients with non-small cell lung cancer between 1979 and 2008. The incidence of lung...

TOPICS:
Advertisement

EClinicalWorks expands Westborough headquarters

June 15, 2010 11:43 am | by Mass Device | Comments

EClinicalWorks LLC buys a 100,000-square-foot Westborough, Mass., building to expand its headquarters. EClinicalWorks purchased a 100,000-square-foot facility to expand its headquarters in Westborough, Mass. The electronic medical records and medical practice management company...

TOPICS:

Talecris Forms Partnership to Co-Promote Life-Saving Rabies Products

June 15, 2010 11:43 am | by Bio-Medicine.Org | Comments

RESEARCH TRIANGLE PARK, N.C. , June 15 /- Talecris Biotherapeutics announced today that it has agreed to a co-promotion arrangement with Novartis Vaccines to jointly market and sell their respective post-exposure rabies products. Talecris provides HyperRAB® S/D (Rabies Immune...

TOPICS:

Combined BRAF-targeted and Immunotherapy Shows Promise for Melanoma Treatment

June 15, 2010 10:37 am | by AACR | Comments

• Oncogenic BRAF contributes to immune escape in melanoma. • MAPK pathway inhibition can release suppression. • BRAF inhibition improves T-cell immune response against cancer. PHILADELPHIA - Combined targeted therapy against the BRAF/MAPK pathway with immunotherapy shows promise as a new...

TOPICS:

BRAF Inhibitor Shows Promising Preclinical Activity Against Melanoma

June 15, 2010 10:37 am | by AACR | Comments

• Phase III trial currently enrolling • Clear tumor regression seen in preclinical models • No increased toxicity observed PHILADELPHIA - Preclinical findings recently published in Cancer Research, a journal of the American Association for Cancer Research, showed RG7204 (PLX4032)...

TOPICS:

FDA Cautions on Accurate Vitamin D Supplementation for Infants

June 15, 2010 9:40 am | by Bio-Medicine.Org | Comments

SILVER SPRING, Md. , June 15 /PRNewswire-USNewswire/ -- The Food and Drug Administration today alerted parents and caregivers that some liquid Vitamin D supplement products are sold with droppers that could allow excessive dosing of Vitamin D to infants.   (Logo:  ...

TOPICS:

DHL Global Mail Launches Specialized Shipping Service for Mail-Order Pharmacies

June 15, 2010 9:40 am | by Bio-Medicine.Org | Comments

WESTON, Fla. , June 15 /- DHL Global Mail today launched a new shipping service designed specifically around the needs of mail-order pharmacies. DHL SMARTMAIL PHARMA SELECT ™ incorporates best practices the mail expediter has established over many years of serving the pharmaceutical...

TOPICS:

Healthy Adviceâ„¢ Networks Physicians Participate in Panel at Sales Force Effectiveness Conference

June 15, 2010 9:40 am | by Bio-Medicine.Org | Comments

CINCINNATI , June 15 /- Healthy Advice ™ Networks, the nation's leading provider of points-of-care health-education programs for consumers and physicians, hosted a panel of their physicians at the recent eyeforpharma Sales Force Effectiveness Conference held in Princeton, New Jersey...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading